Nephros, Inc. (NEPH)

Market Cap	32.84M +117.5%
Revenue (ttm)	18.79M +32.7%
Net Income	1.19M +1,513.5%
EPS	0.11 +1,464.7%
Shares Out	10.64M
PE Ratio	28.05
Forward PE	51.42
Dividend	n/a
Ex-Dividend Date	n/a

Volume	27,067
Open	2.970
Previous Close	2.910
Day's Range	2.950 - 3.177
52-Week Range	1.510 - 6.420
Beta	1.48
Analysts	Strong Buy
Price Target	6.00 (+94.49%)
Earnings Date	Mar 12, 2026

About NEPH

Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities. The company also manufactures and sells water filters that ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Sep 21, 2004
• Employees: 31
• Stock Exchange: NASDAQ
• Ticker Symbol: NEPH
• Website: https://www.nephros.com

Financial Performance

In 2025, Nephros's revenue was $18.79 million, an increase of 32.67% compared to the previous year's $14.16 million. Earnings were $1.19 million, an increase of 1513.51%.

Analyst Summary

According to one analyst, the rating for NEPH stock is "Strong Buy" and the 12-month stock price target is $6.0.

Price Target

$6.0

(94.49% upside)

Analyst Consensus: Strong Buy